Constarium
← Search

Omics · study · 2026

Transcriptional signatures indicating RB function may predict response to CDK4/6 inhibition in endometrial cancer [WES]

Listed in NCBI GEO

RNA sequencing was performed on RNA samples from endometrial cancers from patients who participated in two different abemaciclib combination clinical trials.

Description

For a subset of patients, we also generated genomic DNA from the tumor samples and performed whole exome sequencing. The goal was to determine if the tumors had functional or dysfunctional RB using different transcriptional signatures and then to determine if the RB functional status of the tumor could predict patient response to the CDK4/6 inhibitor in the clinical trial.

Links

Where it is published

Documentation and papers

Topics

Stated by source
Homo sapiens · Other
From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75%
Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE32396613 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:othersource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title